Mersana Therapeutics
Mersana Therapeutics is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop highly targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to cancer patients.
Last updated on
About Mersana Therapeutics
Founded
2001Estimated Revenue
$0-$1MEmployees
51-250Funding / Mkt. Cap
$481MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
CambridgeState
MassachusettsCountry
United StatesTech Stack (91)
